Iterum Therapeutics plc (ITRMF) Other Non-Current Assets (2017 - 2025)

Iterum Therapeutics' Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $19000.0 for Q3 2025.

• In Q3 2025, Other Non-Current Assets rose 216.67% year-over-year to $19000.0; the TTM figure through Sep 2025 stood at $19000.0 (up 216.67% YoY), while the FY2024 annual figure was $5000.0, down 99.13% from the prior year.
• Other Non-Current Assets for Q3 2025 stood at $19000.0, down from $34000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $8.0 million in Q3 2021, with the low at $5000.0 in Q4 2024.
• The 5-year median for Other Non-Current Assets is $34000.0 (2022), against an average of $979263.2.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets sank 99.58% in 2022, then jumped 6970.59% in 2023.
• Iterum Therapeutics' Other Non-Current Assets stood at $64000.0 in 2021, then surged by 3910.94% to $2.6 million in 2022, then sank by 77.48% to $578000.0 in 2023, then slumped by 99.13% to $5000.0 in 2024, then surged by 280.0% to $19000.0 in 2025.
• Business Quant data shows ITRMF's Other Non-Current Assets at $19000.0 in Q3 2025, $34000.0 in Q2 2025, and $34000.0 in Q1 2025.